Clinical studies recruiting near Livonia

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Trinity Health Saint Mary Mercy Livonia Hospital · National Cancer Institute (NCI) · NCT05564390 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · NRG Oncology · NCT05624996 Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A Myel
Phase 2 · Trinity Health Saint Mary Mercy Livonia Hospital · National Cancer Institute (NCI) · NCT07437950 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · Alliance for Clinical Trials in Oncology · NCT07321652 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Trinity Health Saint Mary Mercy Livonia Hospital · Alliance for Clinical Trials in Oncology · NCT07091617 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Trinity Health Saint Mary Mercy Livonia Hospital · SWOG Cancer Research Network · NCT06769126 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · NRG Oncology · NCT05946213 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · NRG Oncology · NCT05174169 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · Alliance for Clinical Trials in Oncology · NCT06931340 Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Phase 2 · Site 107 · Yarrow Bioscience, Inc. · NCT07682896 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · Alliance for Clinical Trials in Oncology · NCT06876714 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Hope Cancer Clinic · National Cancer Institute (NCI) · NCT04269902 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · NRG Oncology · NCT03180268 Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Phase 2 · Trinity Health Saint Mary Mercy Livonia Hospital · Alliance for Clinical Trials in Oncology · NCT06632977 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Hope Cancer Clinic · Alliance for Clinical Trials in Oncology · NCT04242095 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · National Cancer Institute (NCI) · NCT05256225 Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin
Phase 2 · Trinity Health Saint Mary Mercy Livonia Hospital · National Cancer Institute (NCI) · NCT05554393 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · National Cancer Institute (NCI) · NCT06498635 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Trinity Health Saint Mary Mercy Livonia Hospital · NRG Oncology · NCT05327686 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Hope Cancer Clinic · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · NRG Oncology · NCT04852887 Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Phase N/A · Trinity Health Saint Mary Mercy Livonia Hospital · Wake Forest University Health Sciences · NCT03998202 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · Alliance for Clinical Trials in Oncology · NCT05677490 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · National Cancer Institute (NCI) · NCT07198074 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · National Cancer Institute (NCI) · NCT06058377 Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin
Phase 2 · Trinity Health Saint Mary Mercy Livonia Hospital · National Cancer Institute (NCI) · NCT06917911 An Internet-based Program to Help Cancer Survivors Manage Pain
NA · Trinity Health Saint Mary Mercy Livonia Hospital · Wake Forest University Health Sciences · NCT04462302 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Trinity Health Saint Mary Mercy Livonia Hospital · ECOG-ACRIN Cancer Research Group · NCT04239573 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Trinity Health Saint Mary Mercy Livonia Hospital · National Cancer Institute (NCI) · NCT05987241 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · Trinity Health Saint Mary Mercy Livonia Hospital · National Cancer Institute (NCI) · NCT05564377

Look up another city

Look up another condition